<DOC>
	<DOCNO>NCT02189005</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety PreCrea® subject high normal blood sugar level .</brief_summary>
	<brief_title>Study Evaluate Safety Efficacy PreCrea® Subjects With Higher Than Normal Blood Sugar Levels</brief_title>
	<detailed_description>A Prospective , Double Blind , Placebo-Controlled , Randomized , Multicentric , study evaluate efficacy safety PreCrea® , twice-daily dietary supplement people higher normal blood sugar level .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>1 . Age ≥ 18 year ≤ 65 year 2 . Newly diagnose Male Female participants high normal blood sugar level ( FPG &gt; 100 mg/dL ) PreDiabetes Diabetes Mellitus screen treatment 3 . Ability understand willingness sign date write Informed Consent Document screen visit protocol specific procedure perform willing adhere protocol entire trial procedure 1 . Subjects Type 1 Diabetes Mellitus 2 . Participants insulin therapy oral antidiabetic agent uncontrolled diabetes . 3 . Stroke , myocardial infarction , coronary artery bypass graft ( CABG ) percutaneous transluminal coronary angioplasty ( PTCA ) angina pectoris within last 12 month . 4 . Cardiac status New York Heart Association class IIIIV 5 . Uncontrolled blood pressure &gt; 150 mmhg systolic &gt; 100 mmhg diastolic 6 . Impaired renal function show limited serum creatinine ≥ 1.5 mg/dl male ≥ 1.4 mg/dl female 7 . Clinically significant peripheral edema 8 . Clinical evidence active liver disease serum alenine aminotransferase ( ALT ) aspartate amino transferase ( AST ) 2.5 time upper limit normal range ( 2.5 X ULN ) 9 . Participants steroid 10 . Pregnancy lactate woman 11 . Known hypersensitivity study drug 12 . Any malignancy within last 5 year , exception adequately treat basal squamous cell carcinoma skin adequately treat carcinoma insitu . 13 . Current addiction current alcohol abuse history substance alcohol abuse within last 2 year 14 . Subject investigator subinvestigator , research assistant , pharmacist , study coordinator , staff relative thereof directly involve conduct protocol 15 . Mental condition render subject unable understand nature , scope possible consequence study . Subject unlikely comply protocol e.g . uncooperative attitude , inability return follow visit unlikelihood complete study . 16 . Any disease condition opinion investigator and/or sponsor may interfere completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>High blood sugar</keyword>
	<keyword>High HbA1C</keyword>
	<keyword>hyperglycemia</keyword>
	<keyword>Pre-Diabetes</keyword>
	<keyword>Natural Supplement Diabetes</keyword>
</DOC>